Skip to main content
logo
Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
74.38
-0.11 (-0.15%)
Sep 29, 2026, 10:49 AM EDT - Market open

Utah Medical Products Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
10.4911.2913.8716.6416.4714.79
Depreciation & Amortization
2.463.012.856.377.087.28
Stock-Based Compensation
0.40.370.260.230.180.17
Provision & Write-off of Bad Debts
0.360.37-0-0.030.030.02
Other Operating Activities
-0.48-0.66-0.36-0.69-0.4-0.09
Change in Accounts Receivable
-0.130.34-0.842.27-0.51-1.09
Change in Inventory
-0.841.20.59-0.67-2.35-0.49
Change in Accounts Payable
0.140.21-0.07-0.460.46-0.02
Change in Other Net Operating Assets
-0.55-1.43-1.48-1.380.170.59
Operating Cash Flow
11.8514.6914.8322.2821.1521.2
Operating Cash Flow Growth
-16.16%-0.94%-33.44%5.36%-0.26%5.29%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.4-0.37-0.23-0.64-0.81-0.55
Sale of Property, Plant & Equipment
--0.03---
Sale (Purchase) of Intangibles
---0.01--0.01-
Investing Cash Flow
-0.4-0.37-0.21-0.64-0.82-0.55

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
--0.390.120.170.56
Repurchase of Common Stock
-1.85-8.36-19.97--2.5-
Common Dividends Paid
-3.94-3.98-4.26-4.28-3.16-11.47
Financing Cash Flow
-5.79-12.34-23.84-4.17-5.48-10.91

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.30.8-0.680.34-0.77-0.36
Net Cash Flow
5.352.78-9.8917.8214.089.38

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
11.4514.3214.621.6420.3420.65
Free Cash Flow Growth
-17.03%-1.92%-32.53%6.41%-1.52%7.13%
Free Cash Flow Margin
31.70%37.18%35.70%43.09%38.90%42.10%
Free Cash Flow Per Share
3.584.424.175.955.585.64
Levered Free Cash Flow
8.8411.1311.7916.6618.3517.14
Unlevered Free Cash Flow
8.8411.1311.7916.6618.3517.14

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
3.3444.644.834.974.62
Change in Working Capital
-1.380.32-1.8-0.23-2.23-1.01
SEC Filings: 10-K · 10-Q